Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases

Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases

Abstract Background The survival outcomes of neoadjuvant chemotherapy (NACT) versus adjuvant chemotherapy (ACT) for patients with triple-negative breast cancer (TNBC) remain unclear. Therefore, in this study, a meta-analysis was conducted to analyze current evidence on the survival outcomes of NACT...

Full description

Bibliographic Details
Main Authors: Lin-Yu Xia, Qing-Lin Hu, Jing Zhang, Wei-Yun Xu, Xiao-Shi Li
Format: Article
Language:English
Published: BMC 2020-06-01
Series:World Journal of Surgical Oncology
Subjects:
Triple-negative breast cancer
Neoadjuvant
Adjuvant chemotherapy
Survival outcomes
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12957-020-01907-7

Internet

http://link.springer.com/article/10.1186/s12957-020-01907-7

Similar Items